Cell line · CVCL_ZZ39
SW620/AD300
Cancer cell line, Homo sapiens. Colon adenocarcinoma. 3 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. SW620/AD300. Cell lines, record CVCL_ZZ39. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_ZZ39
On this page
Cell line
As Cellosaurus gives it.
- Name
- SW620/AD300
- Accession
- CVCL_ZZ39
- RRID
- RRID:CVCL_ZZ39
- Synonyms
- SW620/AD-300, SW620/Ad300, SW620 Ad300, Ad300
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 51Y
- Category
- Cancer cell line
- Diseases
- Colon adenocarcinoma (NCIt C4349)
- Derived from
- Lymph node (metastatic)
- Parent
- SW620 (CVCL_0547)
- Entry created
- 2020-10-29
- Entry updated
- 2024-12-19
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers3
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Discovery of novel coumarin-containing triazolo[1,5-a]pyrimidine derivatives as potent ABCB1 inhibitor for modulation of multidrug resistance. | J Enzyme Inhib Med Chem | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cells. | MedComm (2020) | 2021 | Cellosaurus cites it | PubMed | |
| Synergistic cytotoxicity of pyrazoloacridine with doxorubicin, etoposide, and topotecan in drug-resistant tumor cells. | Clin Cancer Res | 2004 | Cellosaurus cites it | PubMed |
Relatives2
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | SW620 | CVCL_0547 | Cell lines | |
| Derived from it | SW620/Ad300-ABCB1ko | CVCL_B6Y0 | Cell lines |
Cell banks0
None in this release.
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_ZZ39
GET https://conductscience.org/api/cell-lines/v1/CVCL_ZZ39/problems